LanguaTalk

Surfing the MASH Tsunami

Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL

S4-E16.2 - #NASHDay 2023 Theme: Step Up to NASH!

12 mins; April 15, 2023

S4-E16.1 - What Makes This #NASHDay Different From Previous Years?

8 mins; April 15, 2023

S4-E16 - Stepping Up to International #NASHDay 2023

46 mins; April 12, 2023

S4-E15.5 - From the Vault: Advancing NASH Best Practices In NITs: “Stacking” NASH Biomarkers

13 mins; April 09, 2023

S4-E15.4 - Final Takeaways from Liver Forum 14 and Reviewing the Published Slides

15 mins; April 09, 2023

S4-E15.3 - Session VIII: Stretch Exercise: New Look at Statistics

9 mins; April 08, 2023

S4-E15.2 - Liver Forum 14: Panelists Select Sessions of Interest

11 mins; April 08, 2023

S4-E15.1 - What is The Liver Forum and Initial Impressions

13 mins; April 08, 2023

S4-E15 - Review of Liver Forum 14

53 mins; April 05, 2023

S4-E14.3 - Drug Development News: Phase 3 Press Releases on the Horizon

12 mins; April 04, 2023

S4-E14.4 - International NASH Day 2023 and the Surfing NASH 3rd Anniversary

15 mins; April 04, 2023

S4-E14.2 - NICE and FibroScan for Primary Care: Utilizing Early Detection to Prevent Cirrhosis

12 mins; April 01, 2023

S4-E14.1 - Discussing the 3rd Annual Liver Connect Conference

14 mins; April 01, 2023

S4-E14 - Co-Host Roundtable on the Liver Connect Conference, FibroScan and Pathways, Therapeutic News and More

47 mins; March 31, 2023

S4-E13.6 - From the Vault: Innovations in NAFLD Care Conference: What Is the Importance of Steatosis in Metabolic Health?

18 mins; March 26, 2023

S4-E13.5 - INCBCN 2023: What Will Be Its Impact?

10 mins; March 26, 2023

S4-E13.4 - INCBCN 2023: Not Your Average Conference

11 mins; March 26, 2023

S4-E13.3 - Discussing the Day 2 Program of INCBCN in Barcelona

10 mins; March 25, 2023

S4-E13.2 - Linking NAFLD and NASH to Cancer and Educating on Fatty Liver Screening

10 mins; March 25, 2023

S4-E13.1 - Feedback from the Inaugural INCBCN and Setting the Stage for the 2023 Workshop

9 mins; March 25, 2023

S4-E13 - Previewing the 2023 Innovations in NAFLD Care Workshop

44 mins; March 22, 2023

S4-E12.6 - From the Vault: Building a Disease Model for NASH Prevalence: Key Challenges

13 mins; March 19, 2023

S4-E12.5 - ICER Draft Report: Different Stakeholder Impacts

11 mins; March 19, 2023

S4-E12.4 - Biopsy, Biomarkers and Assessing the Value and Pricing of New Medications

13 mins; March 19, 2023

S4-E12.3 - Keeping Regulatory Pace with Field Advancements

13 mins; March 18, 2023

S4-E12.2 - ICER Draft Report: Assessment of Disease Prevalence and Prospective Drug Efficacy

11 mins; March 18, 2023

S4-E12.1 - Introducing the ICER Draft Report on Resmetirom and Obeticholic Acid for NASH

15 mins; March 18, 2023

S4-E12 - Deep Dive: ICER Draft Report on Resmetirom and Obeticholic Acid for NASH

60 hours 13 mins; March 15, 2023

S4-E11.6 - From the Vault: #NASHDay 2022 Preview: SurfingNASH Predictions

12 mins; March 12, 2023

S4-E11.5 - Excitement and Trepidations: Exploring the Year Ahead in Fatty Liver

9 mins; March 12, 2023

S4-E11.4 - Increasing Incidence of Type-2 Diabetes Among Adolescents

10 mins; March 12, 2023

S4-E11.3 - Fighting for Fair Regulation Around What’s Deemed “Healthy”

10 mins; March 11, 2023

S4-E11.1 - The Surfers Highlight What’s Happening for Fatty Liver in 2023

16 mins; March 11, 2023

S4-E11.2 - Pricing Estimates for Imminent Drug Approvals and the Future Standard of NITs

13 mins; March 11, 2023

S4-E11 - The Yin and Yang of Technology and Regulation

53 mins; March 08, 2023

S4-E10.5 - From the Vault: 2022 Liver Conference: Pediatric NAFLD and Liver Health Education

12 mins; March 05, 2023

S4-E10.4 - Pediatric and Adolescent Fatty Liver: Impact of Emerging Drugs and Trials

7 mins; March 05, 2023

S4-E10.3 - Pediatric and Adolescent Fatty Liver: Implementing Real World Interventions

12 mins; March 04, 2023

S4-E10.2 - Pediatric and Adolescent Fatty Liver: Cardiometabolic Complications and Challenges in NITs

15 mins; March 04, 2023

S4-E10.1 - Increasing Incidence of Pediatric and Adolescent Fatty Liver

9 mins; March 04, 2023

S4-E10 - Focus on Pediatric and Adolescent Fatty Liver Disease

47 mins; March 01, 2023

S4-E9.5 - From the Vault: Discussing Comprehensive Care Models For NAFLD: Metrics, Key Performance Indicators and Improving Management

16 mins; February 26, 2023

S4-E9.4 - Combating Swelling NAFLD and NASH Prevalence: Drugs, Diagnostics and Guidelines for the Frontline

16 mins; February 26, 2023

S4-E9.3 - Diabetes Drug Choices With Benefits For NAFLD

19 mins; February 25, 2023

S4-E9.2 - What’s Behind The New AACE Fatty Liver Guidelines?

16 mins; February 25, 2023

S4-E9.1 - Growing NAFLD-Diabetes Dual Prevalence Increases CVD Risk for Diabetics

16 mins; February 25, 2023

S4-E9 - From the Getting Ahead of the Rising Tide Series: Challenges as a Leading Patient Advocate is Screened

25 mins; February 22, 2023

S4-E8.6 - From the Vault: Previewing Innovations in NAFLD Care 2022: Day Two Sessions

12 mins; February 19, 2023

S4-E8.5 - The Future of Digital Therapeutics

10 mins; February 19, 2023

S4-E8.4 - Digital Apps: Patient Participation and Regulatory Challenges

11 mins; February 19, 2023

S4-E8.3 - Joe Rubinsztain on ChronWell and Scalable Technology

14 mins; February 18, 2023

S4-E8.2 - Feasibility Study: Cognitive Behavior Therapy for Improved Liver Health

13 mins; February 18, 2023

S4-E8.1 - Utilizing Prescription Digital Therapeutics to Combat Fatty Liver

13 mins; February 18, 2023

S4-E8 - Focus on Digital Health with Better Therapeutics and ChronWell

58 mins; February 15, 2023

S4-E7.6 - From the Vault: What’s next in Driving the Global Public Health Agenda for NAFLD?

14 mins; February 12, 2023

S4-E7.5 - Introducing the Rising Tide Podcast and Closing Comments on AASLD Guidance

12 mins; February 12, 2023

S4-E7.4 - AASLD Practice Guidance and Its Influence Outside of the US

9 mins; February 12, 2023

S4-E7.3 - AASLD Guidance and the Practical Impact on Patients Today

10 mins; February 11, 2023

S4-E7.2 - Discussing ALT Cut Off and Utilizing FIB-4 in Primary Care

12 mins; February 11, 2023

S4-E7.1 - Introduction to the AASLD Practice Guidance: Impressions and Overview

11 mins; February 11, 2023

S4-E7 - New 2023 AASLD Practice Guidance

52 mins; February 08, 2023

S4-E6.5 - From the Vault: How NAFLD Patient Advocacy Works: Two Key Pieces

12 mins; February 05, 2023

S4-E6.4 - Accessing New Drugs and the Future of Fatty Liver for Australians

13 mins; February 05, 2023

S4-E6.3 - Linking Cardiovascular Outcomes to Fatty Liver and Utilizing FIB-4 in Australia

14 mins; February 04, 2023

S4-E6.2 - Mapping Fatty Liver in Australia: Prevalence and Subpopulations

11 mins; February 04, 2023

S4-E6.1 - Tony Rahman on Fatty Liver Prevalence in Australia

10 mins; February 04, 2023

S4-E6 - Introduction to NAFLD and NASH in Australia

41 mins; February 02, 2023

S4-E5.6 - From the VAULT: Patient Follow-Up Challenges in Modeling NASH Diagnostics

17 mins; January 29, 2023

S4-E5.5 - Wrap-Up on Data Aggregation and Transparency, Patient Feedback and More

11 mins; January 29, 2023

S4-E5.4 - Patient Data: Security Issues and Proactivity for Empowerment

11 mins; January 29, 2023

S4-E5.3 - Predictive Health Intelligence: Exploring Areas of Application

11 mins; January 28, 2023

S4-E5.2 - How the Predictive Health System Works: Algorithms and Economic Pressures

11 mins; January 28, 2023

S4-E5.1 - Creating a "Combined Informatics and Clinical Program"

13 mins; January 28, 2023

S4-E5 - Predictive Health Intelligence: Using Historic Blood Test Results to Identify Risk of Fatty Liver

55 mins; January 25, 2023

S4-E4.6 - Donna Cryer on Aligning Regulatory Science and Expanding Avenues for Advocacy

14 mins; January 22, 2023

S4-E4.5 - Patient Advocates on “Getting the Message Out” as Approval of Drugs Approaches

14 mins; January 22, 2023

S4-E4.4 - NASH-TAG 2023: Emerging Optimism from a Watershed Moment

12 mins; January 22, 2023

S4-E4.3 - Surfing NASH Community Interview with Caitlin Schneider of Sonic Incytes

20 mins; January 21, 2023

S4-E4.2 - Surfing NASH Community Interview with Jerry Mabary of Chronwell

25 mins; January 21, 2023

S4-E4.1 - Surfing NASH Community Interview with Pamela Danagher of Terns Pharmaceuticals

27 mins; January 21, 2023

S4-E4 - Surfing NASH Audience Reacts to NASH-TAG and the Future of Fatty Liver

75 hours 3 mins; January 19, 2023

S4-E3.6 - Interview with Co-founder & CSO of HistoIndex, Dean Tai, on AI-Assisted Histology

25 mins; January 15, 2023

S4-E3.5 - NASH-TAG Review: Donna Cryer on “Good Regulatory Science”

17 mins; January 15, 2023

S4-E3.4 - NASH-TAG Review: Insights on the F3 Population and AI-Assistance for Improving Therapeutic Efficacy

18 mins; January 15, 2023

S4-E3.3 - NASH-TAG Review: Unpacking Resmetirom Data and Drinking from a Firehose

14 mins; January 14, 2023

S4-E3.2 - NASH-TAG Review: NITs, Clinical Trial Design and Addressing “Indeterminate Zones”

18 mins; January 14, 2023

S4-E3.1 - NASH-TAG Review: Patient Advocate Panel on Influence of New Drugs and Interprofessional Collaboration

13 mins; January 14, 2023

S4-E3 - NASH-TAG Wrap-Up: Therapeutic Efficacy of Resmetirom, NITs and Regulatory Science

75 hours 2 mins; January 11, 2023

S4-E2 - NASH-TAG 2023, Part 2: Friday and Saturday Takeaways and AI-Assisted Histologic Assessment

95 hours 39 mins; January 08, 2023

S4-E1 - NASH-TAG 2023, Part 1: Expansion in NIT Knowledge and How NASH Drug Development is Changing Patient Advocacy Today

77 hours 37 mins; January 07, 2023

S3-E63.3 - Year-End Interview with Ian Rowe

31 mins; January 01, 2023

S3-E63.2 - Year-End Interview with Stephen Harrison

26 mins; December 31, 2022

S3-E63.1 - Year-End Interview with Naim Alkhouri

40 mins; December 30, 2022

S3-E63 - 2022 NAFLD Year-in-Review Interview Series, Part 3

65 hours 21 mins; December 29, 2022

S3-E62.3 - Year-End Interview with Jeff Lazarus

40 mins; December 28, 2022

S3-E62.2 - Year-End Interview with Ken Cusi

40 mins; December 28, 2022

S3-E62.1 - Year-End Interview with Mazen Noureddin

30 mins; December 28, 2022

S3-E62 - 2022 NAFLD Year-in-Review Interview Series, Part 2

65 hours 11 mins; December 26, 2022

S3-E60.5 - Madrigal Announcement on Resmetirom: Combination Therapy and Closing Takeaways

19 mins; December 26, 2022

S3-E60.4 - Madrigal Announcement on Resmetirom: Basic Science and Impact on Future Use of NITs

15 mins; December 26, 2022

Click here to see more

Surfing the MASH Tsunami

Useful pages

Find a tutor

Languages